Continuous exposure of isoprenaline inhibits myoblast differentiation and fusion through PKA/ERK1/2-FOXO1 signaling pathway

Stem Cell Research & Therapy
Shao-Juan ChenJun-Ming Tang

Abstract

The objective of this study is to determine if exuberant sympathetic nerve activity is involved in muscle satellite cell differentiation and myoblast fusion. By using immunoassaying and western blot analyses, we found that β1 and β2-adrenergic receptors (AdR) were expressed in C2C12 cells. The differentiated satellite cells exhibited an increased expression of β2-AdR, as compared with the proliferating cells. Continuous exposure of isoprenaline (ISO), a β-AdR agonist, delayed C2C12 cell differentiation, and myoblast fusion in time- and dose-dependent manner. ISO also increased short myotube numbers while decreasing long myotube numbers, consistent with the greater reduction in MyHC1, MyHC2a, and MyHC2x expression. Moreover, continuous exposure of ISO gradually decreased the ratio of PKA RI/RII, and PKA RI activator efficiently reversed the ISO effect on C2C12 cell differentiation and myoblast fusion while PKA inhibitor H-89 deteriorated the effects. Continuous single-dose ISO increased β1-AdR expression in C2C12 cells. More importantly, the cells showed enhanced phospho-ERK1/2 levels, resulting in increasing phospho-β2-AdR levels while decreasing β2-AdR levels, and the specific effects could be abolished by ERK1/2 inhibitor. Fu...Continue Reading

References

Jul 14, 2000·American Journal of Physiology. Endocrinology and Metabolism·A A SneddonC A Maltin
Dec 8, 2000·Biochimica Et Biophysica Acta·M SalleseA De Blasi
Dec 14, 2004·Journal of Applied Physiology·Jatin G BurnistonDavid F Goldspink
Apr 23, 2005·Science·Robert J Lefkowitz, Sudha K Shenoy
Aug 25, 2007·The Journal of Clinical Investigation·Tadahiro KitamuraDomenico Accili
Mar 25, 2008·American Journal of Physiology. Lung Cellular and Molecular Physiology·Aihua HuMichael M Grunstein
Feb 12, 2009·Neuropathology and Applied Neurobiology·L-E ThornellD Furling
Jul 28, 2009·Neurobiology of Disease·Richard PelletierJack Puymirat
Aug 12, 2009·American Journal of Physiology. Lung Cellular and Molecular Physiology·Gustavo NinoMichael M Grunstein
Oct 31, 2009·Journal of the American College of Cardiology·Filippos TriposkiadisJaved Butler
Jul 23, 2013·Nature·Douglas P MillayEric N Olson
Aug 31, 2013·Circulation Research·Anastasios LymperopoulosWalter J Koch
Nov 26, 2013·Experimental Physiology·P C BrumJ B N Moreira
Mar 19, 2014·Journal of Cellular and Molecular Medicine·Vanessa A VoltarelliPatricia C Brum
May 24, 2014·Circulation Research·Viorel G Florea, Jay N Cohn
Jun 15, 2014·Journal of Molecular Cell Biology·Lucia Garcia-GuerraIria Nieto-Vázquez
Aug 15, 2014·American Journal of Physiology. Cell Physiology·Michael R HicksPaul R Standley
Oct 9, 2014·Mediators of Inflammation·Ana Isabel MartínAsunción López-Calderón
Feb 14, 2015·International Journal of Cardiology·Jun-Ming TangShi-You Chen
Oct 21, 2016·Cell Death & Disease·Sang-Jin LeeGyu-Un Bae
Feb 11, 2018·Stem Cell Research & Therapy·Xiaofan ChenWei Zhang
Mar 27, 2018·Journal of Cellular Physiology·Jacob A RossJulien Ochala
Jun 13, 2018·Frontiers in Neurology·Laurène M AndréBé Wieringa

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
nuclear translocation

Software Mentioned

Image J

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Related Papers

Aviation, Space, and Environmental Medicine
Nelda J MilburnCarol Manning
Experimental Cell Research
D Delain, J P Wahrmann
International Journal of Health Care Quality Assurance
© 2022 Meta ULC. All rights reserved